wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q47393206-7B827D7B-A08E-4FD2-BA8A-471D5DB54699
Q47393206-7B827D7B-A08E-4FD2-BA8A-471D5DB54699
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47393206-7B827D7B-A08E-4FD2-BA8A-471D5DB54699
Hematological adverse effects in breast cancer patients treated with cyclin-dependent kinase 4 and 6 inhibitors: a systematic review and meta-analysis.
P2860
Q47393206-7B827D7B-A08E-4FD2-BA8A-471D5DB54699
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47393206-7B827D7B-A08E-4FD2-BA8A-471D5DB54699
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8530a25c8cbbbe80057cf70de1c1435c3e44d2f9
P2860
A phase 1 study with dose expansion of the CDK inhibitor dinaciclib (SCH 727965) in combination with epirubicin in patients with metastatic triple negative breast cancer.